We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Highlights Contamination Risk for Non-Sterile, Water-Based Drugs
FDA Highlights Contamination Risk for Non-Sterile, Water-Based Drugs
The FDA issued an advisory to drugmakers about the risk of bacterial contamination of non-sterile water-based drug products by Burkholderia cepacian (BCC).